Rhythm Pharmaceuticals Earnings
NASDAQ: RYTMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.68
Rhythm Pharmaceuticals earnings summary
Rhythm Pharmaceuticals is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $-0.68. In its most recent report on Aug 4, 2026 (Q2 2026), RYTM posted EPS of $-0.73. Revenue for the quarter was $71.3 million.
Across the last 16 reports, RYTM shares moved an average of 5.7% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
RYTM earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $-0.73 | — | -0.1% |
| May 5, 2026 | — | $-0.83 | — | -3.9% |
| Feb 26, 2026 | — | $-0.73 | — | +0.9% |
| Nov 4, 2025 | — | $-0.82 | — | -0.9% |
| Aug 5, 2025 | — | $-0.75 | — | +6.1% |
| May 7, 2025 | — | $-0.81 | — | +4.4% |
| Feb 28, 2025 | — | $-0.71 | — | -7.5% |
| Nov 6, 2024 | — | $-0.73 | — | -16.5% |
| Aug 6, 2024 | — | $-0.55 | — | +1.8% |
| May 7, 2024 | — | $-2.35 | — | -3.0% |
| Feb 29, 2024 | — | $-0.70 | — | -4.0% |
| Nov 8, 2023 | — | $-0.76 | — | +18.8% |
| Aug 1, 2023 | — | $-0.82 | — | +9.0% |
| May 2, 2023 | — | $-0.92 | — | -1.2% |
| Mar 1, 2023 | — | $-0.74 | — | -10.0% |
| Nov 8, 2022 | — | $-0.79 | — | -2.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.